Nonsignificant increase seen from 2023; 11.6 percent of adults aged 18 to 64 and 5.1 percent of children aged 0 to 17 were uninsured in 2024.

Treatment with the anaerobe-targeting antibiotic clindamycin was linked to higher rates of gout flares compared with T/S, particularly among patients with CKD.